New breathing technology that improves oxygenation in challenging environments.
Caeli Nova has raised €7.7M across 1 funding round from 3 investors, most recently a Series A round in Jan 2022. Based in London, UK; active in Deeptech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-04 | Series A | €7.7M |
| Latécoère,LG Capital,Ornament Health |
| View deal → |
